Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

306.20INR
22 May 2015
Change (% chg)

Rs-4.10 (-1.32%)
Prev Close
Rs310.30
Open
Rs312.90
Day's High
Rs312.90
Day's Low
Rs301.00
Volume
408,353
Avg. Vol
416,760
52-wk High
Rs358.00
52-wk Low
Rs141.25

CLAI.BO

Chart for CLAI.BO

About

Claris Lifesciences Limited is an India-based holding company. The Company is engaged in drugs and pharmaceuticals. It is a holding company of Claris Injectables, a wholly owned subsidiary dealing in Specialty Injectables business, and Claris Otsuka, an associate of the Company dealing in intravenous nutrition products. Claris... (more)

Overall

Beta: 0.80
Market Cap(Mil.): Rs16,932.38
Shares Outstanding(Mil.): 54.57
Dividend: 9.00
Yield (%): 3.22

Financials

  CLAI.BO Industry Sector
P/E (TTM): 12.18 37.08 39.09
EPS (TTM): 25.48 -- --
ROI: 8.91 16.21 15.55
ROE: 10.23 16.97 16.55
Search Stocks

Cadila Healthcare near deal to buy smaller rival Claris - paper

MUMBAI - Cadila Healthcare Ltd, among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.

21 May 2015

India's Cadila Healthcare near deal to buy smaller rival Claris: paper

MUMBAI - Cadila Healthcare Ltd , among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.

21 May 2015

India's Cadila Healthcare near deal to buy smaller rival Claris - paper

MUMBAI, May 21 - Cadila Healthcare Ltd, among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), the Economic Times newspaper reported on Thursday, citing sources aware of the talks.

21 May 2015

Claris Lifesciences denies talks to sell injectables arm

MUMBAI - Generic drugmaker Claris Lifesciences Ltd said on Thursday it was not in talks to sell its stake in injectable drugs business, and has not considered such an action.

12 Feb 2015

India's Claris Lifesciences denies talks to sell injectables arm

MUMBAI, Feb 12 - Indian generic drugmaker Claris Lifesciences Ltd said on Thursday it was not in talks to sell its stake in injectable drugs business, and has not considered such an action.

12 Feb 2015

Earnings vs. Estimates

Search Stocks